tDCS During Contralaterally Controlled FES for Upper Extremity Hemiplegia
上肢偏瘫对侧控制 FES 期间的 tDCS
基本信息
- 批准号:10658117
- 负责人:
- 金额:$ 68.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2028-04-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdvanced DevelopmentAffectAnodesBilateralBlindedBrainChronicClinicalClinical TrialsCombined Modality TherapyContralateralCross-Over StudiesDoseElectric StimulationElectric Stimulation TherapyElectrodesExtensorFPS-FES OncogeneFingersHandHand functionsHemiplegiaImpairmentInnovative TherapyIntentionInterventionLearningMethodsModalityModelingMotorMotor CortexMovementMuscleNeuronal PlasticityNeuronsOccupational TherapyOutcomeOutputParesisParticipantPatientsPeripheral Nerve StimulationPersonsRandomizedRandomized, Controlled TrialsRehabilitation OutcomeRehabilitation therapyResearchResearch PersonnelStrokeSurfaceTestingTherapeutic EffectThumb structureUnited StatesUpper ExtremityWorkagedbalance recoverychronic strokeclinically relevantconstraint induced movement therapydexteritydisabilityfollow-upfunctional electrical stimulationfunctional improvementhand rehabilitationhemiparesisimprovedimproved outcomeinstrumentmotor recoveryneuromuscular stimulationneurophysiologynoninvasive brain stimulationnovelnovel therapeuticspatient populationpost strokerobot assistancestroke survivorsynergismtherapy developmenttranscranial direct current stimulationupper limb hemiparesis
项目摘要
PROJECT SUMMARY / ABSTRACT
Hemiparesis of the upper-limb is one of the most serious impairments resulting from stroke. Paresis of finger
and thumb extensors is a frequently persisting consequence of stroke, and causes loss of hand function. We
have developed contralaterally controlled functional electrical stimulation (CCFES), a novel neuromuscular
electrical stimulation (NMES) therapy that gives the patient intimate control of both timing and intensity of
stimulation to their finger and thumb extensors and thereby enables intention-driven hand opening and enhanced
functional task practice. Several clinical trials of CCFES-assisted therapy have shown that it reduces impairment
and improves function of the affected upper-limb, and it improves dexterity more than conventional NMES. The
main objective of this study is to build upon the benefits of CCFES-assisted therapy for chronic stroke motor
recovery. One strategy to improve rehabilitation outcomes is to combine treatments that may have synergistic
effects. Therefore, this study applies transcranial direct current stimulation (tDCS) to the motor cortex during
CCFES to determine if the combination of the two will improve outcomes over those achieved by CCFES alone.
TDCS and CCFES may work in synergy to improve outcomes by increasing the concurrent activity of the cortical
neurons within the ipsilesional motor network (conventional tDCS montage) or by exciting the contralesional
networks (unconventional tDCS montage), as suggested by our pilot single-session cross-over study. The
specific aims of the study are: 1) Determine if the addition of tDCS during CCFES improves motor outcomes
over CCFES alone, 2) Estimate the relative effects of two tDCS electrode arrangements on motor outcomes,
and 3) Estimate the relative effects of two tDCS electrode arrangements on neurophysiologic outcomes. We will
conduct a randomized controlled trial in which 63 stroke survivors 6 to 24 months post-stroke will be randomly
assigned to 12 weeks of: a) conventional tDCS during CCFES, b) unconventional tDCS during CCFES, or c)
sham tDCS during CCFES.
Upper extremity impairment, activity limitation and neurophysiologic assessment will
be made at baseline, 6, 12, 24, and 36 weeks. This study is the first RCT of tDCS during CCFES in chronic
upper extremity hemiplegia. The information learned in this study will serve to accelerate the development of
treatments for reducing post-stroke disability.
项目摘要/摘要
上肢轻瘫是中风导致的最严重的损伤之一。手指轻瘫
和拇指伸肌是中风的一个经常持续的后果,并导致手功能的丧失。我们
已经开发出对侧控制功能性电刺激(CCFES),一种新的神经肌肉
电刺激(NMES)治疗,使患者能够密切控制电刺激的时间和强度。
刺激他们的手指和拇指伸肌,从而使意图驱动的手打开和增强
功能性任务实践。几项CCFES辅助治疗的临床试验表明,
并且改善了受影响上肢的功能,并且比传统的NMES更能改善灵活性。的
本研究的主要目的是建立CCFES辅助治疗慢性运动性卒中的益处
复苏改善康复结果的一种策略是将可能具有协同作用的联合收割机治疗与可能具有协同作用的其他治疗相结合。
方面的影响.因此,本研究将经颅直流电刺激(tDCS)应用于运动皮层,
CCFES,以确定两者的结合是否会改善CCFES单独实现的结果。
TDCS和CCFES可以协同工作,通过增加皮质的同时活动来改善结果。
同侧运动网络内的神经元(常规tDCS蒙太奇)或通过刺激对侧运动网络,
网络(非常规tDCS蒙太奇),正如我们的试点单会话交叉研究所建议的那样。的
本研究的具体目的是:1)确定在CCFES期间添加tDCS是否改善运动结果
2)估计两种tDCS电极布置对运动结果的相对影响,
和3)估计两种tDCS电极布置对神经生理结果的相对影响。我们将
进行一项随机对照试验,将63名卒中后6至24个月的卒中幸存者随机
分配至12周:a)CCFES期间的常规tDCS,B)CCFES期间的非常规tDCS,或c)
CCFES期间的假tDCS。
上肢损伤、活动受限和神经生理评估将
在基线、第6、12、24和36周进行。本研究是慢性心力衰竭患者CCFES期间tDCS的首个RCT。
上肢偏瘫本研究中了解到的信息将有助于加快
减少中风后残疾的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Arthur Cunningham其他文献
David Arthur Cunningham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 68.21万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 68.21万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 68.21万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 68.21万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 68.21万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 68.21万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 68.21万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 68.21万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 68.21万 - 项目类别: